| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00295195 |
| P698 | PubMed publication ID | 8456540 |
| P50 | author | Tilman B Drueke | Q47097110 |
| P2093 | author name string | M Daudon | |
| B Lacour | |||
| F Atmani | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity | Q29615342 | ||
| Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies | Q36644826 | ||
| Aggregation of calcium oxalate crystals: Effect of urine and various inhibitors | Q39146435 | ||
| Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation | Q39286733 | ||
| Uromucoids and urinary stone formation | Q39544590 | ||
| Glycosaminoglycans as inhibitors of stone formation | Q39667111 | ||
| Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors | Q39937428 | ||
| Urinary Saturation Measurements in Calcium Nephrolithiasis | Q41602133 | ||
| Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation | Q41738354 | ||
| An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine | Q41812136 | ||
| Modulation of calcium oxalate monohydrate crystallization kinetics in vitro | Q41879161 | ||
| 1 Measurement of molecular weights by electrophoresis on SDS-acrylamide gel | Q43407175 | ||
| Composition and structure of urinary stone | Q44193277 | ||
| Inhibition of calcium oxalate crystallization in urine. | Q50905283 | ||
| Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. | Q52548336 | ||
| The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. | Q54080771 | ||
| Glycoprotein staining following electrophoresis on acrylamide gels. | Q54470239 | ||
| Renal stone formation. The inhibitory effect of urine on calcium oxalate precipitation | Q66916670 | ||
| A new electrophoretic method for the complete separation of all known animal glycosaminoglycans in a monodimensional run | Q66978488 | ||
| Saturation-Inhibition Index as a Measure of the Risk of Calcium Oxalate Stone Formation in the Urinary Tract | Q67431781 | ||
| The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth | Q68250990 | ||
| Growth studies of calcium oxalate in the presence of various ions and compounds | Q68592872 | ||
| Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine | Q69207123 | ||
| Urolithiasis inhibitors and calculus nucleation | Q69352677 | ||
| Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers | Q69416177 | ||
| Partial biochemical and physicochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects | Q70315684 | ||
| Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro | Q70376652 | ||
| Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors | Q70395844 | ||
| [Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis] | Q70516193 | ||
| Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine | Q70664591 | ||
| Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium | Q70729963 | ||
| Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine | Q71070836 | ||
| Tamm Horsfall mucoprotein in urine of potential bladder stone formers | Q71518688 | ||
| Calcium Oxalate Crystalluria and Urine Saturation in Recurrent Renal Stone-Formers | Q71786321 | ||
| Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts | Q71834893 | ||
| Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation | Q72629399 | ||
| The determination of acid aminopolysaccharide in urine | Q74256622 | ||
| A modified uronic acid carbazole reaction | Q79594151 | ||
| Evaluation of the relative inhibitory potential of fractionated urinary macromolecules | Q93625364 | ||
| Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stoneformers | Q93709899 | ||
| P433 | issue | 1 | |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 61-66 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Urological Research | Q15746542 |
| P1476 | title | Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization | |
| P478 | volume | 21 |
| Q77628602 | Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers |
| Q35052256 | Calcium Oxalate Stone Agglomeration Inhibition [tm] Reflects Renal Stone-Forming Activity |
| Q73888392 | Characterization of protein components of human urinary crystal surface binding substance |
| Q72063422 | Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine |
| Q41193178 | Glycosaminoglycans, proteins, and stone formation: adult themes and child's play |
| Q27027510 | Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators |
| Q77878940 | Possible causes for the low prevalence of pediatric urolithiasis |
| Q72581177 | Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers |
| Q41535988 | Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation |
Search more.